The Limited Times

Now you can see non-English news...

For the first time: treatment of corona patients that will prevent hospitalization Israel today

2021-02-15T11:55:12.004Z


| health Patients at risk who are in the first stage of the disease will receive one-time treatment at Hadassah Hospital, which will prevent the aggravation of symptoms and the need for hospitalization. Hadassah Ein Kerem Hospital presents innovative treatment Photo:  Hadassah Spokeswoman For the first time in Israel: The Hadassah Ein Kerem Medical Center launched a new operation today (Monday), which


Patients at risk who are in the first stage of the disease will receive one-time treatment at Hadassah Hospital, which will prevent the aggravation of symptoms and the need for hospitalization.

  • Hadassah Ein Kerem Hospital presents innovative treatment

    Photo: 

    Hadassah Spokeswoman

For the first time in Israel:

The Hadassah Ein Kerem Medical Center launched a new operation today (Monday), which aims to prevent the aggravation of coronary heart disease in patients, and allow them home treatment without hospitalization.

Yesterday, the first verified patients received the innovative treatment, and today another patient joined them.

Corona patients who stay at home and are in the initial stage of the disease, will receive a one-time treatment at the hospital in Jerusalem, which will prevent the aggravation of their disease and the need for hospitalization.

The treatment is performed as a day hospitalization and lasts about two hours, of which one hour is for supervision.

Access to it will be possible by ambulance only, as required by verified Corona patients.

The concentrated antibodies prepared by the company in the process of genetic engineering, if given at an early stage of the disease, help the patient deal with the corona virus and prevent deterioration in the patient's condition and the need for hospitalization.

The treatment consists of monoclonal antibodies that are concentrated in a commercial drug that is allowed for use in Israel and is called: BAMLANIVIMAB.

At Hadassah Ein Kerem, verified patients from the Jerusalem area are called, with risk factors, who begin to develop symptoms of shortness of breath or cough, with an emphasis on the following patient groups: patients with anticonvulsants, chemotherapy patients, dialysis patients, organ transplants, requiring regular treatment with drugs / inhalers , Over age 65.

In order to receive the treatment, one must be equipped with the positive test result and a summary of medical information.

The treatments will be given on weekdays between the hours of 8:00 and 15:00.

As stated, access to Hadassah will be possible through ambulances only (MDA, Rescue Union, private ambulances - under the isolation conditions that meet the rules of the Ministry of Health).

Source: israelhayom

All life articles on 2021-02-15

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.